B-Temia and Sagem (Safran) have signed a technological and business development agreement to develop and market new-generation exoskeletons for industrial and military applications.
Exoskeletons are bio-mechanical and electronic structures worn on the body to assist and enhance people's movements, or to restore mobility.
B-Temia will contribute its experience in human robotics and artificial intelligence, based on its proprietary "Dermoskeleton" technology, already in production for the healthcare sector.
Martin Sion, Chief Executive Officer of Sagem, added, "Our collaboration with B-Temia will enable us to sustain new R&D work on exoskeletons. The collaboration spotlights the dynamic mindset that Sagem seeks to deploy in the application of innovative dual technologies in conjunction with both startups and major corporations."
Ecoskeletons for military applications are being researched upon by Raytheon, Lockheed Martin and several other companies. They are expected to ease the burden of soldiers in combat and field situations.